Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.11091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Dina Lagumdžija und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacy, University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Curcumin, Rosuvastatin Calcium, Renal Insufficiency, Chronic, Dyslipidemias. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of this study was to confirm the effects of curcumin and to investigate the effects of its combination with a reduced dose of rosuvastatin in an adenine-induced model of chronic kidney disease (CKD) and associated dyslipidemia in rats. Renal function and morphology, as well as lipid status, were assessed using laboratory parameters and histopathological analysis. Male Wistar rats (n=36) randomly divided into six groups, were treated for 24 days: normal control (standard diet), CKD control (adenine diet, 0.75% w/w adenine-supplemented diet), curcumin (100 mg/kg/day + adenine diet), rosuvastatin minimal therapeutic dose (MTD) (5 mg/day + adenine diet), rosuvastatin reduced dose (RD, 25% of rosuvastatin MTD + adenine diet), and rosuvastatin RD + curcumin (25% of rosuvastatin MTD + curcumin 100 mg/kg/day + adenine diet) group. While rosuvastatin alone showed only antilipemic action, both curcumin alone and its combination with a reduced dose of rosuvastatin showed better renal protection with lower serum creatinine levels and milder renal morphological alterations, as well as better antilipemic action with lower levels of triglycerides, very low-density lipoprotein (VLDL), and low-density lipoprotein (LDL) cholesterols compared with the levels in CKD control rats. Treatment with curcumin alone also resulted in a significantly higher estimated glomerular filtration rate, lower uric acid levels, and higher high-density lipoprotein (HDL) cholesterol, while the combined therapy additionally resulted in higher serum albumin levels, lower total cholesterol, and both atherogenic and coronary risk indexes compared with CKD control rats. The results of this study confirmed the beneficial effects of curcumin alone and provided new evidence for the beneficial effects of its combination with a reduced dose of rosuvastatin in rats with CKD and associated dyslipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Clinical Pharmacy, University of Sarajevo, Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina.
- Clinic of Nephrology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
- Department for Epidemiology and Biostatistics, University of Sarajevo, Faculty of Medicine, Sarajevo, Bosnia and Herzegovina.
- Department of Pharmacology and Toxicology, University of Sarajevo, Faculty of Medicine, Sarajevo, Bosnia and Herzegovina.
- Department of Histology and Embryology, University of Sarajevo, Faculty of Medicine, Sarajevo, Bosnia and Herzegovina.
- Department of Physiology, University of Sarajevo, Faculty of Medicine, Sarajevo, Bosnia and Herzegovina.
Zitieren
APA
Lagumdžija, D., Hamzić Mehmedbašić, A., Jesenković, D. A., Kudić, B., Kapić, D., Ćosović, E., Lepara, O., Pehlivanović Kelle, B., Prguda-Mujić, J., Kusturica, J., Herenda Pušina, N., Bečić, F., & Kulo Ćesić, A. (2024). Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.11091
Vancouver
Lagumdžija D, Hamzić Mehmedbašić A, Jesenković DA, Kudić B, Kapić D, Ćosović E, et al. Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.11091
BibTeX
@article{Lagumdija2024,
author = {Lagumdžija, Dina and Hamzić Mehmedbašić, Aida and Jesenković, Džan Ahmed and Kudić, Bakir and Kapić, Dina and Ćosović, Esad and Lepara, Orhan and Pehlivanović Kelle, Belma and Prguda-Mujić, Jasminka and Kusturica, Jasna and Herenda Pušina, Naida and Bečić, Fahir and Kulo Ćesić, Aida},
title = {Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.11091}
}
EUVIMED